Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC
- Status
- COMPLETED
- Phase
- PHASE2
2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC
- Status
- COMPLETED
- Phase
- PHASE2
ABI-008 Trial in Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy
- Status
- TERMINATED
- Phase
- PHASE2